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We have developed an assay to study the effect of drugs on 
the proliferation of neonatal human skin-derived keratino- 
cytes in vitro. Expanding populations of neonatal keratino- 
cytes were cultured in low concentrations (0.5%) of fetal calf 
serum for up to 12 d. Growth of the cultures was determined 
by measurement of DNA using a sensitive fluorimetric assay. 
Addition of 10V9- 10m6 M 12(RS)-hydroxy-5,8,10,14-eico- 
satetraenoic acid (12(RS)-HETE) neither stimulated keratin- 
ocyte proliferation nor enhanced the incorporation of 
[3H] thymidine. The ability of neonatal keratinocytes in low 
serum medium to respond to exogenous factors was demon- 
strated by increased growth in response to a mixture of chol- 
era toxin, hydrocortisone, and epidermal growth factor. 
Confluent keratinocyte cultures in 10% human AB serum 
exposed to 12(S)-HETE for 72 h also showed no changes in 
DNA, [3H] thymidine incorporation, or labeling index. Me- 
tabolism of 12(S)-[3H]HETE was greater in cultures con- 
taining low concentrations of serum but there was no evi- 
dence for the formation of 12,20-dihydroxyeicosatetraenoic 
acid. J Invest Dermatol92:683- 688, 2 989 
I ncreased levels of arachidonic acid and its metabolites, partic- ularly the lipoxygenase products, are a feature of the lesional skin of psoriasis [l-4]. The 12-lipoxygenase pathway ap- pears to predominate in adult human epidermis in vitro [5], although it is also reported that 15-lipoxygenase activity is 
higher in neonatal skin keratinocytes [6]. The analysis of scale and 
exudates from psoriatic and normal skin has shown that I2-hy- 
droxy-5,8,10,14-eicosatetraenoic acid (HETE) is the major arachi- 
donate lipoxygenase product in vivo [7,8]. In psoriasis there is ap- 
proximately a threefold increase in the amount of IZHETE 
recovered in exudates of the lesional skin compared with exudates 
from either uninvolved skin or skin of healthy subjects [2]. 
The proinflammatory properties of 12-HETE in human skin are 
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well documented [9- 111. Epicutaneous application to human skin 
causes erythema, edema, infiltration of the dermis with neutrophils 
and mononuclear cells, and migration of neutrophils into the epi- 
dermis with the formation of epidermal microabscesses resembling 
the histopathologic changes seen in the early stages of developing 
psoriatic lesions [12]. The relationshi between increased arachi- 
donic acid lipoxygenation and other eatures of psoriasis, particu- 4 
larly epidermal hyperplasia, is not clear. 12(S)-HETE [13] and the 
5-lipoxygenase products, LTB,, LTC,, and LTD, [ 141, are reported 
to stimulate [3H]thymidine incorporation into confluent adult 
human keratinocyte cultures. An increase in DNA was not demon- 
strated in these studies and it is, therefore, unsafe to conclude that an 
increased rate of keratinocyte proliferation occurred on exposure of 
the cells to the lipoxygenase products. 
Growth assays have been subject to controversy [15]. The accu- 
rate determination of growth rates in expanding cell populations is 
dependent on demonstrating an increase in cell numbers or a rise in 
DNA. For a steady state (confluent) population it is necessary to 
show an increased turnover of cells through the system. Reliance on 
[3H]thymidine incorporation in the absence of prior calibration 
against cell numbers or DNA content may lead to s urious results 
[16- 191. In the present study we have investigate (P the effects of 
1ZHETE on the proliferation of human neonatal keratinocytes 
using a sensitive DNA assay as an end point. Expanding and con- 
fluent cultures were studied. In addition, we substantiated our re- 
sults with measurements of [‘HI thymidine incorporation, cell 
counts, and labeling indices. 
Conditions for keratinocyte culture based on the methods of 
Rheinwald and Green [20] were developed to encourage rapid pro- 
liferation and high yields of cells and as such are unsuitable for 
growth assays. We established a growth factor assay using low con- 
centrations of serum for culture of neonatal skin-derived keratino- 
cytes that limited cell proliferation but in which the cells retained 
their ability to proliferate rapidly in response to a mixture of specific 
exogenous factors. 
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MATERIALS AND METHODS 
Preparation of Keratinocyte Suspensions Neonatal foreskin 
excisions were collected in medium 199 (M199) containing 25 n&l 
N-2-hydroxyethyl-piperazine-N’-2-ethanesulfonic acid (HEPES), 
kanamycin, penicillin (each lOOpg/ml), and amphotericin B (1.25 
pug/ml) and used within 24 h. After three washes in M199, the skin 
was incubated at 37°C in two changes of the same medium for 
15 min each and washed again. Excess dermal tissue was removed 
and the skin cut into l-mm strips, which were incubated in 0.5 mM 
EDTA in phosphate-buffered saline (PBS) [Glasgow formula (g/L), 
NaCl 8.0, KC1 0.2, Na,HPO, * 12HaO 2.9, KHaPO, 0.2, 
EDTA * Na, 0.2, and 5 mg/L phenol red, pH 7.41 containing 2.5 . . . 
mg/ml trypsm and antlblotlcs for 15 h at 4°C. The tissue was trans- 
ferred to Dulbecco’s modified Eagle’s medium (DMEM) contain- 
ing 10% fetal calf serum (FCS), kanamycin, amphotericin-B, and 
1 mM pyruvate, and the epidermis and dermis separated with for- 
ceps. Both components were gently agitated to release the epider- 
ma1 cells, which were filtered through a loo-mesh stainless steel 
gauze and collected by centrifugation at 150g for 5 min at room 
temperature. The cells were washed twice in the same medium, 
counted in a hemocytometer, plated in flasks at 50,000 basal cells/ 
cm*, and incubated in humidified air containing 7.5% CO, at 37°C. 
The plating efficiency was approximately 1% of the basal cells. 
Nonadherent cells were removed at 24 h and subsequent medium 
changes were at 2 -3-d intervals until confluence was reached at 
7- 10 d. Cells were dissociated by washing twice in 0.5 mM eth- 
ylenediaminetetraacetic acid (EDTA) in PBS and incubating in 0.5 
mg/ml trypsin in buffered 0.5 mM EDTA for approximately 5 min 
at 37”C, and then washed twice in DMEM containing 10% FCS. 
The keratinocyte suspensions were used directly in experiments or 
cryopreserved in Ml99 containing 10% dimethyl sulphoxide under 
liquid nitrogen. Frozen cells were rapidly thawed at 37°C and 
washed with DMEM containing 10% FCS, antibiotics, and pyru- 
vate before use. 
Keratinocyte Growth Factor Assays Keratinocytes were plated 
at 18,000 basal cells/cm* in 24 well plates in 1 ml DMEM contain- 
ing 10% FCS, antibiotics, and pyruvate. Nonadherent cells were 
removed at 24 h and the monolayers washed with serum free 
DMEM before continuing culture in DMEM containing 0.5% FCS. 
The 12-HETE was added from a 1000X concentrate stock solution 
in ethanol. Control cultures received ethanol alone to the same final 
concentration of O.l%, or were supplemented with ethanol and a 
mixture of cholera toxin (lo-lo M), hydrocortisone (0.4 pg/ml), 
and human epidermal growth factor (EGF) (10 ng/ml) as control. 
In addition, further control keratinocyte monolayers were cultured 
in DMEM with 10% FCS to demonstrate maximal growth. The 
culture media were changed on alternate days for periods up to 
2 wk. Growth was assessed at intervals by assay of DNA or incorpo- 
ration of [‘Hlthymidine. 
Immunocytochemical Identification of Keratinocytes Sec- 
ond passage keratinocytes grown on glass or plastic coverslips for 
3 d were fixed in acetone (glass) or ethanol (plastic) at -20°C for 
10 min. The fixed cells were incubated overnight at 4°C with 
mouse monoclonal antibodies to cytokeratins AEl (50 and 56 kD 
keratins), AE2 (56 and 65-67 kD keratins), and AE3 (58 and 65- 
67 kD keratins) [21], to desmin and vimentin, followed by incuba- 
tion for I h in rabbit anti-mouse-HRP using the method described 
by Kirkland [22]. 
Mycoplasma Testing Cultures were routinely tested for myco- 
plasma contamination by the fluorescent dye binding method of 
Chen [23]. C 11 g e s rown on coverslips were fixed in Carnoys fixa- 
tive, stained with 0.4 pg/ml bisbenzamide (Hoechst 33258) for 
1 min, and examined using a Leitz Dialux 22 epifluorescence mi- 
croscope. No positives were found. 
DNA Assay Cell monolayers for DNA assay were washed twice 
with 1 ml PBS per well, drained, and stored frozen at - 20°C until 
analyzed. DNA was measured using a modification of the fluorime- 
tric method of Karsten and Wollenberger [24]. The frozen mono- 
layers were thawed, incubated with 1.8 ml/well PBS containing 20 
pg/ml bacterial pronase for 20 min at 37” C, and homogenized in 
situ on ice using a Polytron (Kinematica, Northern Media Supplies, 
U.K.) fitted with a 7-mm probe at speed setting 4.5 for 20 sec. Two 
0.8-ml samples were transferred to plastic tubes to which were 
added 100 ~1 each of 115 pg/ml pronase and 125 pg/ml RNase in 
PBS. The tubes were incubated for 60 min at 37 ’ C and 0.5 ml of 15 
pug/ml ethidium bromide in PBS then added. Fluorescence was 
measured on a Perkin-Elmer LS-2 filter fluorimeter with excitation 
and emission wavelengths of 540 and 580 nm, respectively. The 
assay was standardized against calf thymus DNA (0- 10 pg/ml) 
treated similarly. 
[‘H]Thymidine Incorporation Into DNA Cell monolayers 
were incubated with 1 &i/ml methyl-[3H]thymidine for 18 h. 
Incor 
P 
oration was measured by the method of Dicker and Rozen- 
gurt 251. The cultures were washed three times with PBS, incu- 
bated in fresh 5% trichloroacetic acid for 20 min at 4”C, washed 
twice in ice-cold ethanol, and the TCA insoluble material dissolved 
in 0.1 M sodium hydroxide containing 2% (wt/vol) sodium car- 
bonate overnight at 37°C. Samples of 0.4 ml were neutralized with 
1 M HCl and counted in Monofluor. 
Autoradiography A modification of the scintillation enhance- 
ment method of Durie and Salmon [26] was used. Cell monolayers 
in 24 well plates were labeled with [3H]thymidine as described 
above. The washed monolayers were fixed in ethanol : acetic acid 
(75 : 25) for 10 min, air dried, and then covered with 0.5 ml of 
Amplify fluorographic enhancer for 1 min. The monolayers were 
dried again and overlayed with 0.5 ml K2 emulsion diluted 1: 2 
with 2% glycerol at 45°C. The excess emulsion was drained off by 
inversion of the plates, which were then cooled to 10°C for 30 min 
and air dried. The plates were exposed for 72 h at - 70°C in sealed 
containers. 
The emulsion was developed in Kodak D19, fixed, and air dried 
to prevent distortion during staining with Mayers hematoxylin. 
Random fields in each autoradiograph were scored at 200 times 
magnification. A minimum of 2,000 cells were scored per well. 
Metabolism of 12(S)-[‘H]HETE First passage keratinocytes 
were cultured in six well plates in medium containing either 10% 
FCS or 0.5% FCS supplemented with 12-HETE or the co-factor 
mixture containing cholera toxin, hydrocortisone, and EGF as de- 
scribed for the proliferation assays. At 5 and 12 d the keratinocytes 
were incubated for 2 h in fresh media of the same composition 
containing 1 @/ml 12(S)-rH]HETE. Medium was removed from 
each culture and centrifuged to remove any cellular material. The 
keratinocytes were scraped into fresh medium with a rubber police- 
man. Radioactivity in aliquots of the culture supernatants and cell 
fraction were determined by scintillation counting. The culture 
supernatants were further analyzed by high performance liquid 
chromatography (HPLC) on a RP-18 column eluted with a metha- 
nol : water: acetic acid gradient at 1 ml/min. Fractions collected 
from the reverse phase chromatography HPLC were then analyzed 
on a LiChrosphere Si-60 silica column eluted with a hexane: iso- 
propanol : methanol : acetic acid using a gradient of 98 : 1.2 : 0.8 : 0.1 
to 88 : 7 : 5 : 0.1 generated by curve 8 of a Waters HPLC controller. 
Radioactivity in the HPLC eluent was detected by a Reeve continu- 
ous flow monitor. 
Materials Racemic 12(RS)-HETE was prepared by photooxida- 
tion of arachidonic acid [7]. 12(S)-HETE was prepared by incubat- 
ing arachidonic acid with human platelets isolated according to the 
method of Hamberg et al [27]. In each case the 12-HETE was 
purified by HPLC and purity checked by HPLC on silica and re- 
verse-phase columns and by gas chromatography-mass spectrome- 
try. 12(S)-[3H]HETE was obtained from NEN (DuPont, Steven- 
age, U.K.). 
Tissue culture media and sera were obtained from Gibco-BRL 
(Paisley, Scotland); tissue culture plastics from Becton-Dickinson 
(Oxford, U.K.). Human recombinant EGF was a generous gift from 
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Dr. H. Gregory of ICI Pharmaceuticals, Macclesfield, U.K. Bisben- 
zamide, calf thymus DNA, ethidium bromide, pronase E, ribonu- 
clease A, and hydrocortisone were obtained from Sigma Chemical 
Co. (Poole, U.K.); trypsin 3x crystalyzed from Lorne Diagnostics 
(Reading, U.K.). Monoclonal anti-desmin and anti-vimentin anti- 
bodies were from BCL &ewes, U.K.). Rabbit anti-mouse-HRP was 
from Dako (High Wycombe, U.K.). Monoclonal antibodies for 
cytokeratins @El, AE2, and AE3) were a generous gift from Dr. 
T-T. Sun. Autoradiographic emulsion, type K2, was obtained from 
Ilford (Mobberley, U.K.) and developer D19 from Kodak (Hemel 
Hempstead, U.K.). Amplify fluorographic enhancing scintillant 
and methyl-[3H]thymidine (5 Ci/mmol) were supplied by Amer- 
sham International (Amersham, U.K.). Monofluor scintillation 
cocktail was from National Diagnostics (Aylesbury, U.K.). 
RESULTS 
Keratinocyte Growth in Low Serum Medium Preliminary 
experiments established that primary or up to third passage kerati- 
nocytes plated at 18,000 cells/cm* maintained in DMEM contain- 
ing 10% FCS grew to confluence in approximately 14 d (Fig 1). 
Reduction of the FCS concentration to 0.5% limited growth, but 
supplementation of 0.5% FCS with a mixture of cholera toxin, 
hydrocortisone, and human EGF restored growth to that seen with 
10% FCS, demonstrating that the cells retained their ability to 
proliferate in response to specific exogenous factors. The addition of 
the mixture of co-factors was used as a positive control for the 
growth of keratinocytes in 0.5% FCS in subsequent experiments. 
Cells cultured in 10% FCS were keratin- and vimentin-positive 
and desmin-negative. Positive staining for acidic @El) and basic 
(AE3) keratins was similar to the staining pattern of epithelial cells 
described by Franke et al [28]. Staining was not seen with AE2 
anti-keratin antibody. Cells cultured in 0.5% FCS stained similarly 
to those in 10% FCS. The absence of keratin-negative cells in AEl 
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Figure 1. Growth of keratinocytes expressed as pg DNA/well in 0.5% 
FCS: O-0, 0.5% FCS containing lo-lo M cholera toxin, 0.4 fig/ml hy- 
drocortisone, and 10 ng/ml EGF: Cl--O, or 10% FCS: m-m, in DMEh4. 
Each point is the mean zk SEM of 4 wells. 
Table I. Effect of 12(RS)-HETE on DNA Content and 
[3H]Thymidine Incorporation in Keratinocytes Cultured for 6 Days 
Treatment 
DNA [)H]Thymidine 
(&well) (dpm X 10-3/well) 
0.5% FCS 
0.5% FCS + 12(RS)-HETE 
10-9M 
lO+M 
lo-‘M 
0.5% FCS -I- CT, HC, and EGF 
10% FCS 
5.03 * 0.43 96.6 zk 5.0 
5.32 + 0.51 91.7 f 1.6 
4.92 + 0.44 90.8 f 3.3 
5.12 f 0.55 88.2 I!Z 4.1 
8.66 f 0.17” 168.7 + 11.9” 
7.62 zk 0.67” 140.9 * 5.4” 
Results are expressed as means + SEM, n = 4. 
CT, HC, and EGF: cholera toxin, hydrocortisone, and EGF co-factor mixture. 
. p < 0.05 compared with 0.5% FCS, Student’s t-test. 
and AE~ stained preprations and of desmin staining indicated that 
fibroblasts, endothelial and smooth muscle cells were not present. 
Vimentin staining is a characteristic of many cells, including kera- 
tinocytes, when cultured in vitro [29]. 
Effect of lZ(RS)-HETE on Preconfluent Cultures Second 
passage keratinocytes were established in 10% FCS for 24 h and 
then changed to DMEM with 0.5% FCS containing from 
10wg- 10e7 M 12(RS)-HETE, the vehicle for lZHETE, or the ve- 
hicle and the mixed co-factors as a positive control. The cultures 
received fresh media on days 2 and 4 and were assessed for growth 
on the sixth day. DNA assay showed that lZ(RS)-HETE did not 
stimulate the proliferation of keratinocytes compared with the con- 
trol group given the vehicle. The positive control group containing 
the mixed co-factors showed a significant increase in DNA similar 
to that obtained with cells maintained in 10% FCS (Table I). The 
cultures were pulsed with [3H]thymidine for 18 h on day 5 and the 
uptake measured on the sixth day. Incorporation of [‘Hlthymidine 
was not affected by 12(RS)-HETE whether expressed as disintegra- 
tions per pug DNA or per well. Keratinocyte cultures stimulated 
with the mixture of cholera toxin, hydrocortisone, and EGF and 
cultures exposed to 10% FCS incorporated significantly more 
[3H]thymidine expressed per well compared with cells in 0.5% 
FCS, but the specific activities of the labeled DNA (i.e., cpm/,ug 
DNA) were the same. 
In a similar experiment, keratinocyte cultures were pulsed with 
[3H]thymidine for 18 h starting 6 h after the change of media on the 
fourth day and growth assessed on day 5. Results showing a lack of 
effect of 12(RS)-HETE on DNA content and [‘Hlthymidine incor- 
poration were identical to the results for 6-d cultures. [3H]thymi- 
dine incorporation, however, expressed per pg DNA as well as per 
well, was significantly higher in the positive control cultures con- 
taining 0.5% FCS supplemented with the mixture of co-factors and 
the cultures with 10% FCS compared with the other conditions. 
There was no evidence for a significant loss of cells from the 
monolayers under any condition when supernatants were examined 
by microscopy, or any evidence of change in morphology of kera- 
tinocytes exposed to 12(RS)-HETE when examined by phase con- 
trast microscopy. 
Effect of 12(RS)-HETE on Growth Over a 12-day Time 
Course Because there was no evidence that lZ(RS)-HETE stimu- 
lated proliferation of keratinocytes assessed at single time points in 
preconfluent cultures, a more comprehensive study was made cov- 
ering the time course to 12 d when control cultures, containing 
either 0.5% FCS and the mixture of cholera toxin, hydrocortisone, 
and EGF or 10% FCS, had reached confluence. Second passage 
keratinocytes were plated as described above and switched to 0.5% 
FCS containing lO-8-lO-6 M 12(RS)-HETE. The media were 
changed at 2 or 3-d intervals and growth measured at intervals to 
12 d. Measurements of DNA confirmed that 12(RS)-HETE had no 
appreciable effect on cell proliferation at any time point (Fig 20). A 
small but statistically significant increase in culture DNA was ob- 
served for lo-’ M 12(RS)-HETE between days 5 and 9, but this was 
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Figure 2. Growth of keratinocytes ex osed to 12(RS)-HETE over a 12&y 
time course. A: DNA per well. B: 3Hlthymidine incorporation per fig P 
DNA. (1) 0.5% FCS: O-0, (2) 0.5% FCS + 1O-8 M 12(RS)-HETE: 
0 +**** 0, (3) 0.5% FCS + IO-’ M 12(RS)-HETE: A-&, (4) 0.5% FCS + 
IO+ M lZ(RS)-HETE: A * * *. * k, (5) 0.5% FCS + cholera toxin, hydrocor- 
tisone, and EGF: Cl--O; (6) 10% FCS: B-a. Each point is the mean + 
SEM of 4 wells. 
considerably less than that obtained by the control cultures exposed 
to the mixture of co-factors. 
Although the incorporation of [3H]-thymidine in the various cul- 
ture conditions over this extended time course was more complex, 
the results still indicated that 12-HETE was without effect on ke- 
ratinocyte mitogenesis (Fig 2b). The only statistically significant 
increase in thymidine incorporation per fig DNA for cultures with 
12(RS)-HETE compared with the controls with no HETE was on 
day 5 for keratinocytes exposed to lo-* M 12(RS)-HETE. Cultures 
containing 0.5% FCS and the mixture of co-factors or 10% FCS 
showed the greatest uptake of thymidine perpg DNA before 5 days; 
incorporation of thymidine then declined, particularly for cultures 
containing 10% FCS. At 12 d the incorporation of thymidine was 
similar for all culture conditions. The same results were obtained in 
a second identical experiment. 
Effect of 12(S)-HETE on Confluent Keratinocytes Grown in 
Human AB Serum Alternative culture conditions were used to 
test further the proliferative effects of IZHETE on keratinocyte 
growth. Primary keratinocytes were grown to confluence in 
DMEM containing 10% human AB serum. The cells were then 
exposed to 10m6- 10m9 M 12(S)-HETE for 72 h. Control cultures 
were without 12-HETE or contained the standard co-factor mix- 
ture of cholera toxin, hydrocortisone, and EGF. 
The DNA content did not change with treatment in any group, 
and there was there no stimulation of [3H]thymidine incorporation 
in the cells after exposure to 12(S)-HETE (Table II). Neither the 
labeling indices nor the number of cells per microscope field 
changed after incubation with 12(S)-HETE compared with the 
control cultures. 
Incorporation and Metabolism of 12(S)j3H]HETE Metabo- 
lism of 12(S)-[3H]HETE was analyzed under the conditions de- 
scribed above for expanding cultures at 5 d and confluent cultures at 
12 d. The results were ualitatively similar but quantitatively the 
incorporation of 12(S)- ‘H]HETE into the cells was about 50% 9 
higher for the 12-d cultures. Keratinocytes cultured for I2 d in 
medium containing 0.5% FCS incorporated 22% of the 12(S)- 
[“HIHETE during the 2-h incubation. Inclusion of lo-‘M 12(W)- 
HETE or the mixture of cholera toxin, hydrocortisone, and EGF in 
the growth media before and during incubation with 12(S)- 
PH]HETE had no effect on the incorporation of 12(S)-[3H]HETE, 
(20% and 25%, respectively). In cultures containing 10% FCS, 
however, the incorporation of 12(S)-[3H]HETE into the cells was 
less than 5%. 
Analysis of the culture supernatants by reverse phase HPLC 
showed increased metabolism of 12(S)-[3H]HETE by keratinocytes 
in cultures containing 0.5% FCS compared with cells in 10% FCS 
(Fig 3). Before exposure of keratinocyte cultures in 0.5% FCS to 
either lo-’ M 12(RS)-HETE or a mixture of cholera toxin, hydro- 
cortisone, and EGF for 5 or 12 d did not affect the metabolism of 
12(S)-[3H]HETE. The peak of radioactivity eluting at 24 min on 
the reverse phase column co-chromatographed with authentic 
12(RS)-HETE and rechromatography on a silica column confirmed 
its identity as unchanged substrate. Greater than 50% of the 12(S)- 
[3~]~~~~ was metabolized by cultures in low serum media com- 
pared with less than 15% in the presence of 10% FCS. Metabolism 
of 12(S)-[3H]HETE did not occur in the absence of cells. Five major 
and several minor metabolites were detected by reverse phase and 
silica HPLC, but none of the products co-chromatographed with 
Table II. Effect of 12(S)-HETE for 72 Hours on DNA Content, [3H]Thymidine Incorporation, Cell Counts, and Labeling Index of 
Confluent Cultures of Keratinocytes Grown in Medium Containing 10% Human AI3 Serum 
DNA 
Treatment @g/well) 
10% AB serum 18.2 f 0.38 
10% AB serum + 12(S)-HETE 
10-9M 17.8 z!z 0.97 
IO-sM 19.2 f 0.46 
1 O-‘M 16.8 f 0.33 
10-6M 17.6 + 0.60 
10% AB serum + CT, HC, and EGF 17.8 f 0.36 
Results are expressed as means f SEM, n = 4. 
CT, HC, and EGF: cholera toxin, hydrocortisone, and EGF co-factor mixture. 
[3H]Thymidine 
(dpm/well) 
1030 f 82 
1148 z!z 132 
988 f 86 
1224 + 83 
878 f 56 
1263 f 57 
Ceils/200x 
Field 
580 + 30 
599 + 36 
658 f 33 
622 f 29 
599 + 30 
594 + 16 
Labeling 
Index 
4.5 f 1.3 
3.4 f 1.1 
4.3 z!z 1.0 
4.4 rt 1.4 
5.2 f 1.1 
7.8 f 0.9 
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Figure 3. Reverse phase chromatography of 12(S)-[3H]HETE metabolites 
in supematants from 12-day cultures of keratinocytes. A: 0.5% FCS. B: 10% 
FCS. Elution positions of authentic 12-HETE and 12,20-diHETE are 
shown. 12(S)-[3]HETE incubated in medium containing 0.5% FCS but no 
cells gave a trace similar to B. Methanol in the solvent gradient: . . . . . . 
authentic 12,20-diHETE, a potential metabolite of 12-HETE by 
w-oxidation, in both of the systems. 
DISCUSSION 
Our evidence suggests that IZHETE does not increase the prolifer- 
ation rate of human neonatal foreskin-derived keratinocytes ob- 
tained from healthy subjects. Our conclusions that 12-HETE is not 
a growth factor, based on total DNA measurements in addition to 
the incorporation of [3H] thymidine, are the same whether expand- 
ing or confluent cultures in media containing either fetal calf or 
human serum were studied. In similar studies we have also been 
unable to demonstrate that LTB,, a 5-lipoxygenase product of ara- 
chidonic acid, promotes keratinocyte proliferation (manuscript in 
preparation). 
The results of this study fail to substantiate the conclusions of 
Kragballe and Fallon [13] that 12-HETE stimulates the synthesis of 
DNA in confluent primary cultures of adult human skin-derived 
keratinocytes. An explanation for the difference could be that neo- 
natal foreskin-derived keratinocytes are less responsive to 12-HETE 
than the cells prepared from adult skin. Alternatively, the experi- 
mental conditions, which differed in many respects between the 
two studies, such as medium composition, type and concentration of 
serum, and nature of the substrate, may affect the response of cul- 
tured keratinocytes to 12-HETE. In our experiments we used kera- 
tinocytes that had been passaged, making unlikely a contribution 
from contaminating fibroblasts, melanocytes, and Langerhans cells, 
which are common in primary isolates of epidermal cells. 
Many techniques for keratinocyte culture have been developed to 
give maximal cell growth [20,30] and as such are unlikely to show 
further increase in proliferation in response to the inclusion of addi- 
tional growth factors. In the growth factor assay we developed, 
keratinocytes were cultured on plastic in medium containing a low 
concentration of fetal calf serum to give submaximal keratinocyte 
proliferation. We demonstrated, however, that the low serum me- 
dium supplemented with a mixture of specific growth factors could 
support rapid proliferation of keratinocytes as defined by measure- 
ment of increased DNA content of the cultures. In preliminary 
studies (data not shown) we found that the components of the 
positive control mixture of co-factors individually promoted kera- 
tinocyte proliferation although none was as effective as the com- 
plete mixture or 10% FCS. Identification of the cells in low serum 
medium as keratinocyte was confirmed by immunocytochemical 
staining. A growth assay similar to ours was used by Wilkinson to 
demonstrate that serine can stimulate keratinocyte proliferation 
PII. 
In the earlier study by Kragballe and Fallon [ 131 an increase in the 
incorporation of [3H]thymidine was presumed to indicate increased 
synthesis of DNA in cultures exposed to platelet derived IZHETE. 
This conclusion, however, was not supported by any change of the 
DNA content of the cultures. It is necessary to be cautious when 
interpreting the results of [3H]thymidine incorporation into cells. A 
cultured breast epithelial cell line showed no change in DNA con- 
tent on stimulation with estradiol but increased thymidine incorpo- 
ration by 40% [18]. Potten [32] h as reviewed evidence that epithe- 
lial cells can store nucleotides without incorporation into DNA. 
Recently it was shown that human keratinocytes can catabolize 
thymidine [ 191. In general, the measurement of DNA or cell num- 
bers over a time course is the best indice of proliferation of cells in 
culture. 
12-HETE in lesional psoriatic skin was initially identified as the 
12(S) isomer [I] but recent stereochemical analysis has shown that a 
substantial proportion of the 12-HETE in psoriatic scale has the 
12(R) configuration [33]. The 12(R) isomer is biologically active, 
being more potent than 12(S)-HETE in neutrophil chemokinesis 
[34] and lymphocyte chemotaxis [35] assays. The significance of 
12(R)-HETE in psoriasis is not fully understood. As sufficient quan- 
tities of the 12(R)-HETE isomer were unavailable we used chemi- 
caly prepared racemic 12(RS)-HETE in several of the growth assays. 
Although 12-HETE is reported to cause epidermal hyperplasia 
when applied to guinea pig ears [36,37], it cannot be concluded that 
1ZHETE directly stimulated keratinocyte proliferation. Mitogenic 
factors may be released in the tissues as a result of the inflammatory 
reaction. At present there is no clear evidence indicating an effect of 
IZHETE on epidermal proliferation in human skin in vivo. 
We have demonstrated that 12(S)-HETE is metabolized by ke- 
ratinocytes under the conditions used for the proliferation assays. 
Metabolism of 12(S)-HETE was less in cultures containing high 
concentrations of serum, the estimated half-life being 6 h in cul- 
tures with 10% FCS and 2 h with 0.5% FCS. None of the metabo- 
lites could be identified as 12,20-diHETE, a known metabolite of 
IZHETE in polymorphonuclear leukocytes by the o-oxidation 
pathway [38]. This data, taken in conjunction with our earlier re- 
sults that human skin releases only small amounts of 12,20-diHETE 
in vivo [39], implies that the metabolism of 12-HETE by w-oxida- 
tion is not of significance in human skin. Increased in vitro 12-h- 
poxygenase activity in uninvolved psoriatic epidermis has been re- 
ported [40]. Although the raised levels of 12-HETE in lesional 
psoriatic skin probably result from increased synthesis due to the 
higher levels of arachidonic acid substrate [1,2] and lipoxygenase 
activity, this cannot be confirmed until metabolism has been studied 
in more detail. Arachidonic acid metabolism by the lipoxygenase 
pathways is abnormal in psoriasis. Our data from experiments on 
keratinocytes obtained from neonatal human skin do not support 
the view that the increase in proliferative activity in psoriasis is 
likely to result from the mitogenic activity of IZHETE, although 
we cannot exclude the possibility that cells from adult skin behave 
differently. The inflammatory properties of IZHETE may be of 
greater significance in this disease. 
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